APOB and hepatocellular carcinoma: In HCC, low expression of APOB was related to increased expression of metastatic and oncogenic regulators (FOXM1, MTIF, HGF, CD44, and ERB2) and to the downregulation of tumor suppressors, such as PTEN and TP53.